Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Radko Komers, MD, PhD
Travere Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uniklinik Köln, Klinik Und Poliklinik Für Kinder- Und Jugendmedizin
Cologne, Germany
Recruiting - Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Recruiting - Universitätsklinikum Heidelberg - Angelika Lautenschläger - Kinderklinik
Heidelberg, Germany
Recruiting
- Policlinico Bari Ospedale Pediatrico Giovanni Xxiii
Bari, Italy
Recruiting - Irccs Istituto Giannina Gaslini
Genova, Italy
Recruiting - Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
Recruiting - Azienda Ospedale Università Di Padova
Padova, Italy
Recruiting - Ospedale Pediatrico Bambino Gesù
Roma, Italy
Recruiting
- Emma Kinderziekenhuis
Amsterdam, Netherlands
Recruiting - Radboud Universitair Medisch Centrum
Nijmegen, Netherlands
Withdrawn
- Uniwersytecki Szpital Dziecięcy W Krakowie
Krakow, Poland
Recruiting - Instytut Centrum Zdrowia Matki Polki
Lodz, Poland
Withdrawn - Instytut Pomnik - Centrum Zdrowia Dziecka
Warsaw, Poland
Withdrawn
- Hospital Universitari Vall D'Hebrón
Barcelona, Spain
Recruiting - Hospital Universitario 12 de Octubre
Madrid, Spain
Recruiting - Hospital Universitario la Paz
Madrid, Spain
Recruiting - Hospital Universitario Virgen del Rocío
Seville, Spain
Recruiting
- Drottning Silvias Barn- Och Ungdomssjukhus
Gothenburg, Sweden
Recruiting - Karolinska Universitetssjukhuset Huddinge
Stockholm, Sweden
Recruiting
- University Hospitals Bristol and Weston Nhs Foundation Trust, Bristol Royal Hospital for Children
Bristol, United Kingdom
Recruiting - Nhs Greater Glasgow and Clyde, Royal Hospital for Children
Glasgow, United Kingdom
Recruiting - Alder Hey Children'S Nhs Foundation Trust
Liverpool, United Kingdom
Recruiting - Great Ormond Street Hospital for Children Nhs Foundation Trust
London, United Kingdom
Recruiting - Manchester University Nhs Foundation Trust
Manchester, United Kingdom
Recruiting
- Cedars-Sinai Medical Center
Los Angeles, California, United States
Recruiting - Nemours Children'S Hospital
Wilmington, Delaware, United States
Recruiting - Nicklaus Children'S Hospital
Miami, Florida, United States
Recruiting - University of Miami, Leonard M. Miller School of Medicine
Miami, Florida, United States
Recruiting - University of Iowa, Stead Family Children'S Hospital
Iowa City, Iowa, United States
Withdrawn - Floating Hospital for Children at Tufts Medical Center
Boston, Massachusetts, United States
Withdrawn - C.S. Mott Children'S Hospital
Ann Arbor, Michigan, United States
Recruiting - University of Minnesota, Masonic Children'S Hospital
Minneapolis, Minnesota, United States
Recruiting - Children'S Mercy Hospitals and Clinics
Kansas City, Missouri, United States
Recruiting - Hackensack University Medical Center
Hackensack, New Jersey, United States
Recruiting - Jersey Shore University Medical Center
Neptune City, New Jersey, United States
Recruiting - Cohen Children'S Medical Center
New Hyde Park, New York, United States
Recruiting - Fink Children'S Ambulatory Care Center
New York, New York, United States
Withdrawn - University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Recruiting - Atrium Health Levine Children'S Hospital
Charlotte, North Carolina, United States
Completed - Duke Molecular Physiology Institute
Durham, North Carolina, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Aug 2021
- Primary completion
- 12 Mar 2027
- Completion
- 12 Apr 2027
- Last update posted
- 12 May 2026
- Registered enrollment
- 67
- Registry id
- NCT05003986
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.